Viewing Study NCT05552469


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2025-12-25 @ 8:32 PM
Study NCT ID: NCT05552469
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2022-09-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module